Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve H Thorne

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Expert Reviews in Molecular Medicine|January 13, 2010
Enhancing biological therapy through conditional regulation of protein stabilitySteve H Thorne
Current Opinion in Molecular Therapeutics|August 7, 2008
Oncolytic vaccinia virus: from bedside to benchtop and backSteve H Thorne
Expert Opinion on Biological Therapy|December 8, 2006
Strategies to achieve systemic delivery of therapeutic cells and microbes to tumorsSteve H Thorne
Methods in Molecular Biology (Clifton, N.J.)|September 28, 2011
Next-generation oncolytic vaccinia vectorsSteve H Thorne
Frontiers in Oncology|July 3, 2014
Immunotherapeutic potential of oncolytic vaccinia virusSteve H Thorne
Immunologic Research|July 1, 2011
Immunotherapeutic potential of oncolytic vaccinia virusSteve H Thorne
Trends in Cancer|March 23, 2016
Adding STING to the Tale of Oncolytic VirotherapySteve H Thorne
Methods in Molecular Biology (Clifton, N.J.)|July 2, 2009
Design and testing of novel oncolytic vaccinia strainsSteve H Thorne
Immunotherapy|August 2, 2013
The role of GM-CSF in enhancing immunotherapy of cancerSteve H Thorne
Oncolytic Virotherapy|August 12, 2016
Arming viruses in multi-mechanistic oncolytic viral therapy: current research and future developments, with emphasis on poxvirusesPadma Sampath, Steve H Thorne
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Expert Reviews in Molecular Medicine|January 13, 2010
Enhancing biological therapy through conditional regulation of protein stabilitySteve H Thorne
Current Opinion in Molecular Therapeutics|August 7, 2008
Oncolytic vaccinia virus: from bedside to benchtop and backSteve H Thorne
Expert Opinion on Biological Therapy|December 8, 2006
Strategies to achieve systemic delivery of therapeutic cells and microbes to tumorsSteve H Thorne
Methods in Molecular Biology (Clifton, N.J.)|September 28, 2011
Next-generation oncolytic vaccinia vectorsSteve H Thorne
Frontiers in Oncology|July 3, 2014
Immunotherapeutic potential of oncolytic vaccinia virusSteve H Thorne
Immunologic Research|July 1, 2011
Immunotherapeutic potential of oncolytic vaccinia virusSteve H Thorne
Trends in Cancer|March 23, 2016
Adding STING to the Tale of Oncolytic VirotherapySteve H Thorne
Methods in Molecular Biology (Clifton, N.J.)|July 2, 2009
Design and testing of novel oncolytic vaccinia strainsSteve H Thorne
Immunotherapy|August 2, 2013
The role of GM-CSF in enhancing immunotherapy of cancerSteve H Thorne
Oncolytic Virotherapy|August 12, 2016
Arming viruses in multi-mechanistic oncolytic viral therapy: current research and future developments, with emphasis on poxvirusesPadma Sampath, Steve H Thorne
Pageof 4